HEAL Committee Meeting
Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.
For an advanced search, use Publication Search tool.
If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.
Publication Selector by Date
Dates with dots provide a link to available publications.
37th Parliament ,2nd Session
(September 30, 2002 - November 12, 2003)
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
January | ||||||
---|---|---|---|---|---|---|
Sun | Mon | Tue | Wed | Thu | Fri | Sat |
1
|
2
|
3
|
4
|
|||
5
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
13
|
14
|
15
|
16
|
17
|
18
|
19
|
20
|
21
|
22
|
23
|
24
|
25
|
26
|
28
|
29
|
30
|
31
|
February | ||||||
---|---|---|---|---|---|---|
Sun | Mon | Tue | Wed | Thu | Fri | Sat |
1
|
||||||
2
|
4
|
5
|
6
|
7
|
8
|
|
9
|
11
|
13
|
14
|
15
|
||
16
|
18
|
20
|
21
|
22
|
||
23
|
25
|
26
|
27
|
28
|
March | ||||||
---|---|---|---|---|---|---|
Sun | Mon | Tue | Wed | Thu | Fri | Sat |
1
|
||||||
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
13
|
14
|
15
|
16
|
18
|
20
|
21
|
22
|
||
23
|
25
|
27
|
28
|
29
|
||
30
|
31
|
April | ||||||
---|---|---|---|---|---|---|
Sun | Mon | Tue | Wed | Thu | Fri | Sat |
1
|
3
|
4
|
5
|
|||
6
|
8
|
9
|
10
|
11
|
12
|
|
13
|
14
|
15
|
16
|
17
|
18
|
19
|
20
|
21
|
22
|
23
|
24
|
25
|
26
|
27
|
May | ||||||
---|---|---|---|---|---|---|
Sun | Mon | Tue | Wed | Thu | Fri | Sat |
1
|
2
|
3
|
||||
4
|
6
|
8
|
9
|
10
|
||
11
|
13
|
15
|
16
|
17
|
||
18
|
19
|
20
|
21
|
22
|
23
|
24
|
25
|
27
|
29
|
30
|
31
|
June | ||||||
---|---|---|---|---|---|---|
Sun | Mon | Tue | Wed | Thu | Fri | Sat |
1
|
2
|
3
|
5
|
6
|
7
|
|
8
|
12
|
13
|
14
|
|||
15
|
16
|
17
|
18
|
19
|
20
|
21
|
22
|
23
|
24
|
25
|
26
|
27
|
28
|
29
|
30
|
July | ||||||
---|---|---|---|---|---|---|
Sun | Mon | Tue | Wed | Thu | Fri | Sat |
1
|
2
|
3
|
4
|
5
|
||
6
|
7
|
8
|
9
|
10
|
11
|
12
|
13
|
14
|
15
|
16
|
17
|
18
|
19
|
20
|
21
|
22
|
23
|
24
|
25
|
26
|
27
|
28
|
29
|
30
|
31
|
August | ||||||
---|---|---|---|---|---|---|
Sun | Mon | Tue | Wed | Thu | Fri | Sat |
1
|
2
|
|||||
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
13
|
14
|
15
|
16
|
17
|
18
|
19
|
20
|
21
|
22
|
23
|
24
|
25
|
26
|
27
|
28
|
29
|
30
|
31
|
September | ||||||
---|---|---|---|---|---|---|
Sun | Mon | Tue | Wed | Thu | Fri | Sat |
1
|
2
|
3
|
4
|
5
|
6
|
|
7
|
8
|
9
|
10
|
11
|
12
|
13
|
14
|
15
|
17
|
19
|
20
|
||
21
|
22
|
26
|
27
|
|||
28
|
Retrieving Calendars...
Historical Note
Notice of Meeting publications are only available starting September 2003.
HOUSE OF COMMONS | CHAMBRE DES COMMUNES | |||||||
2nd Session, 37th Parliament | 2e Session, 37e législature | |||||||
NOTICE OF MEETING | AVIS DE CONVOCATION | |||||||
Standing Committee on Health | Comité permanent de la santé | |||||||
AMENDED | MODIFIÉ | |||||||
Meeting No. 69 | Séance no 69 | |||||||
Tuesday, November 4, 2003 | Le mardi 4 novembre 2003 | |||||||
9:00 a.m. to 12:00 p.m. | 9 h 00 à 12 h 00 | |||||||
| ||||||||
Orders of the Day | Ordre du jour | |||||||
Prescription Drugs | Médicaments sur ordonnance | |||||||
9:00 a.m. to 10:30 a.m. | 9 h 00 à 10 h 30 | |||||||
Witnesses | Témoins | |||||||
Rx & D - Canada's Research-Based Pharmaceutical Companies | Rx & D - Les compagnies de recherche pharmaceutique du Canada | |||||||
Murray J. Elston, President | Murray J. Elston, président | |||||||
John Stewart, Chairman and Executive Vice-President and General Manager of Purdue Pharma | John Stewart, président du Conseil et Vice-président et directeur général de Purdue Pharma | |||||||
Nestor Nituch, Director of Clinical Research Bristol Myers Squibb (BMS) | Nestor Nituch, directeur de recherche clinique Bristol Myers Squibb (BMS) | |||||||
BIOTECanada | BIOTECanada | |||||||
Janet Lambert, President | Janet Lambert, présidente | |||||||
Suzanne Cadden, Vice President of Clinical and Regulatory Affairs Lorus Therapeutics | Suzanne Cadden, vice-présidente des affaires réglementaires et clinique Lorus Therapeutics | |||||||
Canadian Generic Pharmaceutical Association | Association canadienne du médicament générique | |||||||
Allan Oberman, Vice-Chair, President and Chief Executive Officer of Novopharm Ltd. | Allan Oberman, vice-président, président et chef de la direction de Novopharm Ltée. | |||||||
Jim Keon, President | Jim Keon, président | |||||||
10:30 a.m. to 12:00 p.m. | 10 h 30 à 12 h 00 | |||||||
(In Camera) | (À huis clos) | |||||||
Consideration of Draft Report | Étude de projet de rapport | |||||||
Le greffier du Comité | ||||||||
José Cadorette ((613) 995-4108) | ||||||||
Clerk of the Committee | ||||||||
2003/11/03 2:43 p.m. | 2003/11/03 14 h 43 |